Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course London 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Join Discussions
    • BOPA Forums
    • BOPA forum FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » ISOPP

ISOPP

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 27/04/20 by Sara Gacia

Cost-minimization analysis for determination of genetic polymorphisms in clinical practice

View resources
Last reviewed: 27/04/20 by Melanie B. Bernhardt

Developing pediatric oncology pharmacy services in Sub-Saharan Africa

View resources
Last reviewed: 27/04/20 by Melanie Dalby

Pre-dispensing oral systemic anti-cancer therapy in the breast cancer clinic

View resources
Last reviewed: 27/04/20 by Karunrat Tewthanom

Prevalence of adverse events and factors affecting adverse events in Chronic Myelogenous Leukemia patients receiving BCR-ABL tyrosine kinase inhibitors at Siriraj Hospital

View resources
Last reviewed: 27/04/20 by Louisa Knowles

Providing an out of hours chemotherapy/monoclonal antibody service without an out of hours aseptic unit at the Queen Elizabeth Hospital, Birmingham

View resources
Last reviewed: 27/04/20 by Islam Elkonaissi

Risk assessment of hyperglycaemia induced by steroid use for immunotherapy toxicity in non-small cell lung cancer (NSCLC) patients

View resources
Last reviewed: 27/04/20 by Sandrine von Grünigen

Safe handling of cytotoxic medicines in low and middle income countries – An overview of practices

View resources
Last reviewed: 09/02/23 by Jonathan W. Barrett

Service evaluation of the non-medical prescribing (NMP) service at a regional cancer centre

View resources
Last reviewed: 17/03/21 by Jane Hippenmeyer

Stability of the Trastuzumab Biosimilar ABP 980 after intravenous (IV) bag preparation, transport and storage at various temperatures, concentrations and stress conditions

View resources
Last reviewed: 27/04/20 by Nadjoua Maouche

Streamlining the delivery of chemotherapy for lymphoma patients

View resources
Last reviewed: 27/04/20 by Chun-Nan Kuo

The effectiveness of collaboration between oncology pharmacists and anesthesiologists for cancer pain managements in a medical center in Taiwan

View resources
Last reviewed: 27/04/20 by Han Shan

The influence of body mass index on the survival outcome for Chinese diffuse-large B-cell lymphoma patients treated with RCHOP

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 6 7 8 … 13 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.